Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
about
13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal StudyLong-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.Diabetes mellitus and renal involvement in chronic viral liver disease.Risk Factors for Renal Functional Decline in Chronic Hepatitis B Patients Receiving Oral Antiviral Agents.Estimated Glomerular Filtration Rate Increases in Chronic Hepatitis B Patients Treated With Telbivudine Monotherapy and Combination Treatment.Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.DNA polymerase inhibitors for treating hepatitis B: a safety evaluation.Prevalence of chronic kidney disease in patients with chronic hepatitis B: A cross-sectional survey.The prevalence and association of chronic kidney disease and diabetes in liver cirrhosis using different estimated glomerular filtration rate equation.Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort.Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults.Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study
P2860
Q35704622-4A61A470-8FFA-4D3C-838E-26387BDC63D7Q35952819-3FDC6ECC-A681-49E9-9DD8-CF494937A96AQ36067389-503A7F40-38E8-48BF-B3BA-6CC6F85F6F25Q36309960-8279C19F-9912-46F4-A645-C1CA0EFF00ECQ36445048-B4E134E0-D6CA-44C8-B2B6-E11CC474F476Q36805345-DBF25BE0-6090-4151-ABDA-B38D4CAB7333Q37593985-1D6CEA1B-CD66-4E16-9CE9-B2EDF36FB444Q38692333-4B0BC5C0-D7FD-4D19-A9EB-3BC01EDF0401Q40172897-3AD29793-928C-4893-B6B3-6F1EC94914F5Q49299108-86FC7767-F82D-432B-9D75-3C5006C91408Q52386061-A0D88DDA-3FC8-4023-A53E-893804BEAE0DQ55333063-BC632762-F608-4B64-BEA9-B1B5A22F9FE0Q55422411-840B6373-81AE-443F-A350-0BFC6D12792BQ57469986-B4D0870F-6F70-4BE3-9DBD-7D619F767078
P2860
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@en
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@nl
type
label
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@en
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@nl
prefLabel
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@en
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prevalence of renal abnormalities in chronic HBV infection: the HARPE study
@en
P2093
Dominique G Larrey
Dominique Thabut
Gilbert Deray
Jean-Pierre Bronowicki
Marc Bourliere
Sabine Amet
Victor de Ledinghen
Yves Benhamou
P2860
P304
P356
10.1111/LIV.12480
P577
2014-03-03T00:00:00Z